Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism
Rev. Assoc. Med. Bras. (1992); 63 (8), 2017
Summary Objective: The pathogenesis of recurrent priapism is currently being investigated based on the regulation of the phosphodiesterase 5 (PDE5) enzyme. We explored the daily use of PDE5 inhibitors to treat and prevent priapism recurrences. Method: We administered PDE5 inhibitors using a long-term t...
Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5/metabolismo, Estudios de Seguimiento, Inhibidores de Fosfodiesterasa 5/administración & dosificación, Priapismo/enzimología, Priapismo/prevención & control, Estudios Prospectivos, Recurrencia, Prevención Secundaria, Tadalafilo/administración & dosificación